Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.

Journal of pediatric endocrinology & metabolism : JPEM - 1 Sept 2014

Raygada Margarita, King Kathryn S, Adams Karen T, Stratakis Constantine A, Pacak Karel

Abstract excerpt

The discovery that mutations in the succinate dehydrogenase (SDH) complex subunit (SDHA, B/C/D/AF2) genes predispose patients to the development of tumors has led to the identification of a large population of patients and relatives at risk for developing malignancies. The most frequent condition...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Counseling
Share to Genetic Predisposition to Disease
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Neoplasms

Share to Phenotype

Share to Succinate Dehydrogenase

Share to Uncertainty

Source

Open in PubMed Open full text

Identifiers

PMID: 24854530
DOI: 10.1515/jpem-2013-0369
PMCID: PMC4718145

Genes

SDHA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24854530-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.PMID 24854530Read ↗

Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriersSemantic proximity Read ↗

The Role of the Surgical Pathologist in the Recognition of Hereditary SDH-Deficient Tumor Syndromes.Semantic proximity Read ↗

Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Succinate Dehydrogenase-deficient TumorsSemantic proximity Read ↗

Four generations of SDHB-related disease: complexities in management.Semantic proximity Read ↗

Succinate Dehydrogenase Mutations as Familial Pheochromocytoma Syndromes.Semantic proximity Read ↗

A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.Semantic proximity Read ↗

A study of succinate dehydrogenase deficient tumourigenesis : from functional assessment of variant pathogenicity to the discovery of new disease biomarkersSemantic proximity Read ↗

A Review of Genomic Testing and SDH ‐ Deficiency in Gastrointestinal Stromal Tumors: Getting to the GISTSemantic proximity Read ↗

International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriersSemantic proximity Read ↗

Gene of the month: SDH.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.